2023 SOHO® Brazil: "How I Sequence New Agents in First and Second Li…

SOHO Brazil 2023

A. Moskowitz

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Medias…

ecancer

E. Zucca

Updates From the ECHELON-1 Trial Utilizing Brentuximab in Hodgkin’s …

PrecisCa

M. Kamdar

A+AVD in Frontline cHL: Barriers and Challenges

Hackensack Meridian John Theurer Cancer Center

T. Feldman

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Indy Hematology Review

M. Lunning

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

Stephen M. Ansell

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Clas…

EHA 2022 Conference Coverage

J. Radford

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse …

Anna Sureda

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

R. C. Lynch

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lymphoma

SOHO Highlights: State of the Art and Next Questions

N. Bartlett

Updates in Management of Hodgkin Lymphoma

Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

J. Svoboda